Relenopride Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRelenopride Hydrochloride
Drug Alias Namerelenoprida瑞仑必利瑞诺必利relenopridumrelenopride +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsConstipationIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSK Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSk Life Science IncSk Chemicals Co Ltd
Active IndicationsN/A
Inactive IndicationsConstipationIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A